P. Cosmo Smith, MBA, managing partner, Origin Commercial Ventures, discusses The Breakthrough Oncology Accelerator flagship program.
P. Cosmo Smith, MBA
Advertisement
Articles by P. Cosmo Smith, MBA
P. Cosmo Smith, managing partner, Origin Commercial Ventures, discusses how Origin improves patient access in oncology.
P. Cosmo Smith, MBA, managing partner, Origin Commercial Ventures, discusses the difference between clinical liquidity and financial liquidity.
Advertisement
Latest Updated Articles
Cosmo Smith on the Difference Between Clinical Liquidity and Financial LiquidityPublished: October 5th 2018 | Updated:
Cosmo Smith on How Origin Improves Patient AccessPublished: October 12th 2018 | Updated:
Cosmo Smith on The Breakthrough Oncology Accelerator Flagship ProgramPublished: October 17th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5